RITTER PHARMACEUTICALS INC 4
4 · RITTER PHARMACEUTICALS INC · Filed Jun 30, 2015
Insider Transaction Report
Form 4
Doyle Noah
Director
Transactions
- Conversion
Convertible Preferred Stock
2015-06-29−1,247,804→ 0 total(indirect: by Javelin Venture Partners, L.P.)→ Common Stock (1,247,804 underlying) - Conversion
Common Stock
2015-06-29+1,247,804→ 2,047,804 total(indirect: by Javelin Venture Partners, L.P.) - Conversion
Common Stock
2015-06-29+322,753→ 322,753 total(indirect: By LLC) - Conversion
Convertible Preferred Stock
2015-06-29−322,753→ 0 total(indirect: By LLC)→ Common Stock (322,753 underlying)
Footnotes (4)
- [F1]Effective on the date of the closing of the issuer's initial public offering, the Convertible Preferred Stock of the issuer held by Javelin Venture Partners, L.P. converted into Common Stock of the issuer on a one-for-one basis and had no expiration date.
- [F2]As the managing director of Javelin Venture Partners, L.P. the reporting person may be deemed the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
- [F3]Effective on the date of the closing of the issuer's initial public offering, the Convertible Preferred Stock of the issuer held by Javelin Venture Partners I SPV I, LLC converted into Common Stock of the issuer on a one-for-one basis and had no expiration date.
- [F4]As the managing director of Javelin Venture Partners I SPV I, LLC, the reporting person may be deemed the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.